Viret Jean-Frederic

CIK 00014275694 companiesALISO VIEJO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001427569

Recent Transactions

50 trades

Award
SpyGlass Pharma, Inc.$SGP
Stock Option (right to buy)
2026-02-05+17,500→ 17,500 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−450,000→ 0 total
Disposition from Tender
NGM BIOPHARMACEUTICALS INC
Common Stock
2024-04-05−3,038→ 0 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-12-01+450,000→ 450,000 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-02-01$21.55/sh−7,402→ 61,295 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-02-01$10.05/sh+7,402→ 68,697 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-02-01−7,402→ 54,167 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-25$10.05/sh+40,000→ 107,439 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-25$20.10/sh−40,000→ 67,439 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-25−40,000→ 61,569 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-25$19.00/sh−6,144→ 61,295 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-11+62,500→ 62,500 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-11+31,250→ 67,439 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-10$18.18/sh−4,080→ 36,189 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-11-17$13.50/sh+1,500→ 40,269 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-11-17−1,500→ 110,241 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-11-17$17.49/sh−1,995→ 38,769 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-10-14$19.00/sh−6,144→ 40,423 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-05-20$17.66/sh−1,278→ 46,567 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-02-19$22.33/sh−3,159→ 46,841 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-02-19−3,159→ 101,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-02-19$10.05/sh+3,159→ 50,000 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-15$19.67/sh−3,520→ 49,639 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-15$20.08/sh−2,798→ 46,841 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-15−6,318→ 104,728 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-15$10.05/sh+6,318→ 53,159 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-10+19,365→ 22,668 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-10$17.73/sh−7,077→ 15,591 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-10+62,500→ 62,500 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-01-10+31,250→ 46,841 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-11-20−3,159→ 111,046 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-11-20$19.59/sh−3,159→ 3,303 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-11-20$10.05/sh+3,159→ 6,462 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-11-18$18.88/sh−3,112→ 3,303 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-10-18$19.02/sh−1,388→ 6,385 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-10-16−3,159→ 114,205 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-10-16$19.00/sh−3,159→ 7,773 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-10-16$10.05/sh+3,159→ 10,932 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-09-23$21.78/sh−740→ 7,773 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-09-18$10.05/sh+3,159→ 11,672 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-09-18$20.44/sh−3,159→ 8,513 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-09-18−3,159→ 117,364 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-08-21−6,318→ 120,523 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-08-21$20.73/sh−260→ 14,571 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-08-21$10.05/sh+6,318→ 14,831 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-08-21$21.75/sh−6,058→ 8,513 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-08-19$19.04/sh−3,000→ 8,513 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-06-19$20.81/sh−100→ 11,513 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-06-19$10.05/sh+3,159→ 14,672 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2019-06-19$20.32/sh−3,059→ 11,613 total

Companies

Recent Filings

Address

C/O SPYGLASS PHARMA, INC. 27061 ALISO CREEK RD., SUITE 100

ALISO VIEJO, CA, 92656

View on SEC.gov